NOTICE OF REDEMPTION AND SETTLEMENT AGREEMENTNotice of Redemption and Settlement Agreement • September 27th, 2013 • Advaxis, Inc. • Pharmaceutical preparations • New York
NOTICE OF REDEMPTION AND SETTLEMENT AGREEMENT (the “Agreement”) is made as of the 26th day of September 2013 by and among Advaxis, Inc., a Delaware corporation (the “Company”), Optimus Capital Partners, LLC, a Delaware limited liability company, dba Optimus Life Sciences Capital Partners, LLC (“Optimus Life Sciences”), Optimus CG II, Ltd., a Cayman Islands exempted Company (“Optimus CG II”), Socius CG II, Ltd., a Bermuda exempted Company (“Socius” and collectively with Optimus Life Sciences, Optimus CG II and their respective designees, the “Investors”), and, solely for purposes of Section 2.4, Crede CG III, Ltd., a wholly owned-subsidiary of Crede Capital Group, LLC. (“Crede”).
